Scientific Publications - Arcellx

News & Presentations

06.22.2020

Chimeric antigen receptors incorporating novel binding domains targeting CD123 direct potent antitumor activity of T cells: Correlation between affinity and activity (Abstract 3243). Presented at the American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting II.

05.29.2020

Selective targeting of HER2-overexpressing solid tumors with a next-generation CAR-T cell therapy (Abstract 3041). Presented at the American Society of Clinical Oncology (ASCO) 2020 Annual Meeting.

04.29.2020

Novel CAR-T Cell therapy that can be activated, silenced, and reprogrammed in vivo with soluble protein adapters in a dose dependent manner (Abstract 788). Presented at the American Society of Gene & Cell Therapy (ASGCT) 2020 Annual Meeting.

04.17.2019

Chimeric Antigen Receptors Incorporating D Domains Targeting CD123 Direct Potent Mono- and Bi-specific Antitumor Activity of T Cells. Mol Ther. 2019 Jul 3; 27(7): 1262–1274. Published online 2019 Apr 17. doi: 10.1016/j.ymthe.2019.04.010. .